Why so quiet?

Apologies for light posting as of late. I’ve been buried deep in revisions to Building Biotechnology and prepping for an upcoming talk. Writing is coming to a close, so soon I’ll be looking for external reviewers and case study contributions.
For those of you attending BIO 2008, I’ll be presenting in a session on trends in [...]

Journal of Commercial Biotechnology — March 2008

The March 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract of each article:
Volume 14, Issue 2
Editorial
Yali Friedman
A new approach to improve technology commercialisation in university medical schools
Courtney Price, Richard Huston and Arlen D Meyers
Export compliance for life sciences
John Avellanet

Drug Patent Expirations in April 2008

Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in April 2008*Drugs may be covered by multiple patents

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration

ACTINEX
Univ Az Cancer Ctr
masoprocol
4,695,590
APR 17,2008

ACTINEX
Univ Az Cancer Ctr
masoprocol
5,008,294
APR 15,2008

ESTROSTEP 21
Warner Chilcott
ethinyl estradiol; norethindrone acetate
5,010,070
APR 23,2008

ESTROSTEP FE
Warner Chilcott
ethinyl estradiol; norethindrone acetate
5,010,070
APR 23,2008

FEMPATCH
Parke Davis
estradiol
5,006,342
APR 09,2008

LODINE XL
Wyeth Pharms Inc
etodolac
4,966,768
APR 30,2008

ORFADIN
Swedish Orphan
nitisinone
5,006,158
APR 09,2008

ZEMURON
Organon Usa Inc
rocuronium bromide
4,894,369
APR 13,2008

Courtesy of DrugPatentWatch.com